Letter: Beyond Feasibility: The Need for Longer Duration and Composite NIT Endpoints in Biopsy‐Free MASH Trials

Alimentary Pharmacology & Therapeutics 2026

View at publisher

Authors: Wenbin Dai, Guochun Zhang

DOI: 10.1111/apt.70701

Cited by: 1

References: 3

Fields of Study & Subjects

Esophageal Cancer Research and Treatment Hepatocellular Carcinoma Treatment and Prognosis Ultrasound and Hyperthermia Applications

References 3